Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Stryker ( (SYK) ) is now available.
On March 11, 2026, Stryker Corporation identified a cybersecurity incident that disrupted its global Microsoft-based information technology environment, and on March 12, 2026, Chief Information Security Officer Dave Nathans briefed customers and cybersecurity professionals on the situation. The company reported ongoing disruptions to order processing, manufacturing and shipping but said it does not believe patient-related services or connected products have been affected, while its investigation continues and the full operational and financial impact remains unknown.
The most recent analyst rating on (SYK) stock is a Hold with a $370.00 price target. To see the full list of analyst forecasts on Stryker stock, see the SYK Stock Forecast page.
Spark’s Take on SYK Stock
According to Spark, TipRanks’ AI Analyst, SYK is a Neutral.
The score is driven by strong underlying fundamentals and constructive 2026 guidance, including sustained growth and margin expansion. Offsetting this are weak technicals (trading below major moving averages), a rich valuation (high P/E with low yield), and added near-term risk from the unresolved cybersecurity incident and tariff-related headwinds.
To see Spark’s full report on SYK stock, click here.
More about Stryker
Stryker Corporation is a global medical technology company that provides a wide range of medical devices and equipment, including products used in surgery, orthopedics and patient care. The company focuses on supplying hospitals and healthcare providers with critical tools and systems that support clinical procedures and patient treatment across international markets.
Average Trading Volume: 1,935,504
Technical Sentiment Signal: Hold
Current Market Cap: $132.3B
For detailed information about SYK stock, go to TipRanks’ Stock Analysis page.

